Insights into subclinical rejection

Transplantation Proceedings

Volumn 36, Issue 2 SUPPL., 2004, Pages S71-S73

  Rush, D ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT INFLAMMATORY FACTOR 1; AZATHIOPRINE; CYCLOSPORIN A; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 4; LYMPHOCYTE ANTIBODY; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RANTES; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIOPSY; CADAVER KIDNEY; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; RISK FACTOR; SIDE EFFECT; SUBCLINICAL REJECTION; TREATMENT OUTCOME;

EID: 1642339652     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2003.12.051     Document Type: Article

References (33)

1. United States Renal Data System 2001 Annual Data Report. Atlas of End-Stage Renal Disease in the United States, Chapter 7 Transplantation. Am J Kid Dis. 38:2001;S117.
2. Hariharan S., Johnson C.P., Bresnahan B.A., et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med. 342:2000;605.
3. Paul L.C. Chronic allograft nephropathy an update. Kidney Int. 56:1999;783.
4. Meier-Kriesche H.-U., Ojo A.O., Hanson J.A., et al. Increased impact of acute rejection on chronic allograft failure in recent era. Transplantation. 70:2000;1098.
5. Racusen L.C., Solez K., Colvin R.B., et al. The Banff 97 Working Classification of Renal Allograft Pathology. Kidney Int. 55:1999;713.
6. Rush D.N., Henry S.F., Jeffery J.R., et al. Histological findings in early routine biopsies of stable renal allograft recipients. Transplantation. 57:1994;208.
7. Rush D.N., Nickerson P., Gough J., et al. Beneficial effects of treatment of early subclinical rejection a randomized study. J Am Soc Nephrol. 9:1998;2129.
8. Nickerson P., Jeffery J.R., Gough J., et al. The effect of increasing baseline immunosuppression on the prevalence of clinical and subclinical rejection a pilot study. J Am Soc Nephrol. 10:1999;1801.
9. Rush D. (Pro). Controversies in nephrology protocol biopsies should be part of the routine management of kidney transplant recipients. Am J Kidney Dis. 40:2002;671.
10. Legendre C., Thervet E., Skhiri H., et al. Histologic features of chronic allograft nephropathy revealed by protocol biopsies in kidney transplant recipients. Transplantation. 65:1998;1506.
11. Nankivell B.J., Fenton-Lee C.A., Kuypers D.R.J., et al. Effect of histological damage on long-term kidney transplant outcome. Transplantation. 71:2001;515.
12. Jurewicz W.A. Immunological and nonimmunological risk factors with tacrolimus and Neoral in renal transplant recipients an interim report. Transplant Proc. 31:1999;S64.
13. Gloor J.M., Cohen A.J., Lager D.J., et al. Subclinical rejection in tacrolimus-treated renal transplant patients. Transplantation. 73:2002;1965.
14. Rush D.N., Jeffery J., Gough J., et al. Predicting rejection is early diagnosis achievable and important? Graft. 2:1999;31.
15. Karpinski M., Rush D., Jeffery J., et al. Flow cytometric cross-matching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity cross-match. J Am Soc Nephrol. 12:2001;2807.
16. Grimm P.C., McKenna R., Nickerson P., et al. Clinical rejection is distinguished from subclinical rejection by increased infiltration by a population of activated macrophages. J Am Soc Nephrol. 10:1999;1582.
17. Lipman M.L., Shen Y., Jeffery J.R., et al. Immune-activation gene expression in clinically stable renal allograft biopsies molecular evidence for subclinical rejection. Transplantation. 66:1998;1673.
18. 2 in renal allograft rejection. Lancet. 318:1981;431.
19. Ramos E.L., Barri Y.M., Croker B.P., et al. Thromboxane synthase expression in renal transplant patients with rejection. Transplantation. 59:1995;490.
20. Grimm P, Nickerson P, Rush D, et al: Lack of phenotypic difference in the cellular infiltrate between subclinical and clinical allograft rejection. Am Soc Transplant Phys An Mtg, Chicago, Abstract 275, 1997.
21. Isoniemi H.M., Krogerus L., von Willebrand E., et al. Histopathological findings in well-functioning, long-term renal allografts. Kidney Int. 41:1992;155.
22. Sijpkens Y.W.J., Doxiadis I.I.N., Mallat M.J.K., et al. Early versus late acute rejection episodes in renal transplantation. Transplantation. 75:2003;204.
23. Shishido S., Asanuma H., Nakai H., et al. The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy. J Am Soc Nephrol. 14:2003;1046.
24. Birk PE, Stannard KM, Konrad HB, et al: Surveillance biopsies are superior to functional studies for the diagnosis of acute and chronic renal allograft pathology in children. Pediatr Transplant (in press).
25. Sarwal M., Chua M.-S., Kambham N., et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med. 349:2003;125.
26. Roberti I., Reisman L., Burrows L., et al. Urine cytology and urine flow cytometry in renal transplantation - a prospective double blind study. Transplantation. 59:1995;495.
27. Vasconcellos L.M., Schachter A.D., Zheng X.X., et al. Cytotoxic lymphocyte gene expression in peripheral blood leukocytes correlates with rejecting renal allografts. Transplantation. 66:1998;562.
28. Hricik D.E., Rodriguez V., Riley J., et al. Enzyme linked immunosorbent spot (ELISPOT) assay for interferon-gamma independently predicts renal function in kidney transplant recipients. Am J Transplant. 3:2003;878.
29. Li B., Hartono C., Ding R., et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med. 344:2001;947.
30. Beik A.I., Morris A.G., Higgins R.M., et al. Serial flow cytometric analysis of T-cell surface markers can be useful in differential diagnosis of renal allograft dysfunction. Clin Transpl. 12:1998;24.
31. Rush D., Somorjai R., Deslauriers R., et al. Subclinical rejection - a potential surrogate marker for chronic rejection - may be diagnosed by protocol biopsy or urine spectroscopy. Ann Transplant. 5:2000;44.
32. Clarke W., Silverman B., Zhang Z., et al. Characterization of renal allograft rejection by urinary proteomic analysis. Ann Surg. 237:2003;660.
33. Schaub S, Rush D, Wilkins J, et al: Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J Am Soc Nephrol (in press).